About
Branded Generics
Areas of Focus
Categories
Generic DrugAfrica
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
4
As Collaborator
7
Total Enrollment
1,219
By Phase
NA: 2PHASE3: 1PHASE1: 6PHASE4: 1
By Status
COMPLETED: 7UNKNOWN: 2NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07015346Lead Sponsor
Adhesion and Safety of Rotigexole Compared to Neupro®
NANot yet recruiting
40 participants
Started: Sep 1, 2025 · Completed: Oct 30, 2025
NCT06286098Collaborator
Alpha Lipoic Acid in Pediatrics on Hemodialysis
PHASE3Enrolling by invitation
50 participants
Started: Feb 2, 2025 · Completed: Apr 1, 2027
NCT05798715Collaborator
Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)
PHASE1Completed
30 participants
Started: Nov 29, 2022 · Completed: Jan 13, 2023
NCT05813496Lead Sponsor
Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt
PHASE4Completed
430 participants
Started: Oct 26, 2022 · Completed: Dec 11, 2024
NCT05491330Collaborator
Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium)
PHASE1Completed
28 participants
Started: Aug 21, 2022 · Completed: Oct 27, 2022
Locations (1)
Headquarters
Giza, Egypt
Map
Loading map...